Finally had time to go through the 3Q10Q. Take a look at Item 1A
To service our indebtedness and other obligations, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control, and any failure to meet our debt obligations could harm our business, financial condition and results of operations.
I anticipate another stock offering and futher dilution. It's the only way to survive
LUVE sets Mexican sporting goods market on fire. Gain potential now wide open
Get the full LUVE profile at:is(dot)gd/Rcau1U
(replace "(dot)" with ".")
Thanks. I couldn't for the life of me figure out what in the filings last night was leading to this pop, but knew it must be something.
As per SEC filing on December 16, Bioscrip and the relevant State and Federal regulatory agencies have reached an agreement in principle regarding the Exjade distribution issue from the legacy business. ($15 M as reserved for in 3Q 10Q.) This removes a significant overhang from the stock.
This stock recently caught my interest. IF a buyout was to happen, then I would predict BIOS would go for $11-12 per share, however I can't bank on a future buyout now. It's a real shame because their revenue is strong and actually on the rise but their cash flow is terrible as of late, and it's leading to poor negative EPS. I don't know if it's a combination of budgeting issues, investments gone bad, or what, but if whatever investments that they made don't start producing more cash, then upper management will be in hot water to make some changes. However, buyout aside, I still believe that there can be growth and strong EPS in the future of this company. I'm going to be keeping an eye on it.
A change in sentiment might have been one factor. Huge losses in income on the quarterly statements was the more significant factor. When is net income expected to be in the black again, if ever? Just curious.
in my opinion. All lawsuits and allegations of fraudulent and/or illegal activity aside, for me, two decades is just too long a period of time for any good and viable business model not too bear fruit.
Hi wrgrace. My comment was made largely in reference to the negative spamming that appears to have taken over this board lately. For what it's worth, my take on BIOS is - This is a company that has been in business now for close to 20 years (about 12 as a publicly traded company and another 8 or so as a privately held enterprise). Over the last 12 months they have lost about .65/share (better than 43 million dollars). I give a company what I believe to be a reasonable period of time to bottom line in black ink - after which - I cut them loose. In my view, 20 years constitutes more than just a delay in being able to turn consistently and increasingly profitable. Such an expanse of time without becoming consistently profitable calls into question their business model -
After reading through many of the recent posts here, I think the above just may be about the only intelligent post on this board recently......
Are you nuts, BIOS was recently near $18, revenue is strong and it continues to take market share. Only reason shares are down was a change in sentiment which brought shares down, that can and will-- chance on a dime. A buyout is likely down the road, but absurdly cheap valuation here at the moment.
Sentiment: Strong Buy
CVS just bought Coram...I think RAD has to do something in the PBM, Home Care space to stay "COMPARATIVE" to CVS, WAG. Maybe we could join forces, team up, you think?
Yup, load up, multiple ways to gain big upside with BIOS. Just a short-term bear raid going on at the moment.
Sentiment: Strong Buy